Thomas Boyd

Chief Market Intelligence Officer, United States and Canada at GE Healthcare in November 2019 to January 2021

Head of Winthrop Business at Sanofi in September 2018 to November 2019

Head of Commercial Excellence, Mylan Pharmaceuticals at Mylan in December 2017 to July 2018

Head of Pricing and Contracts, North America at Mylan in April 2016 to November 2017

Vice President, Portfolio Business Development, North America at Mylan in November 2014 to March 2016

Director of Business Operations, Established Products Business Unit, AsiaPac at Pfizer in June 2012 to October 2014

Director, Worldwide Hospital Sterile Injectables, Asia at Pfizer in September 2011 to June 2012

Director, Market Analytics & Strategy - Biosimilars Business Unit at Pfizer in March 2011 to October 2011

Commercial Implementation Lead, Established Products Business Unit, Europe at Pfizer in October 2010 to February 2011

Strategy and Business Development Lead - Established Products Business Unit, Japan at Pfizer in November 2009 to September 2010

Senior Manager, Market Analytics and Forecasting at Pfizer in January 2009 to October 2009

Commerical Analytics Manager at Pfizer in February 2008 to December 2008

Senior Auditor/Audit Supervisor at Pfizer in July 2006 to January 2008

Senior Finance Analyst at IBM in January 2005 to January 2006

Program Manager at Applied Materials in August 2000 to June 2003

Supervisor, Management Program at McMaster-Carr in June 2000 to July 2001

Military Officer, Combat Engineer at United States Army in June 1995 to May 1999